GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vita Life Sciences Ltd (ASX:VLS) » Definitions » Cash Flow for Dividends

Vita Life Sciences (ASX:VLS) Cash Flow for Dividends : A$-5.17 Mil (TTM As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Vita Life Sciences Cash Flow for Dividends?

Vita Life Sciences's cash flow for dividends for the six months ended in Dec. 2024 was A$-1.91 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2024 was A$-5.17 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Vita Life Sciences's quarterly payment of dividends increased from Dec. 2023 (A$-1.62 Mil) to Jun. 2024 (A$-3.26 Mil) but then declined from Jun. 2024 (A$-3.26 Mil) to Dec. 2024 (A$-1.91 Mil).

Vita Life Sciences's annual payment of dividends increased from Dec. 2022 (A$-3.04 Mil) to Dec. 2023 (A$-3.37 Mil) and increased from Dec. 2023 (A$-3.37 Mil) to Dec. 2024 (A$-5.17 Mil).


Vita Life Sciences Cash Flow for Dividends Historical Data

The historical data trend for Vita Life Sciences's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vita Life Sciences Cash Flow for Dividends Chart

Vita Life Sciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.97 -2.90 -3.04 -3.37 -5.17

Vita Life Sciences Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.46 -1.75 -1.62 -3.26 -1.91

Vita Life Sciences Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-5.17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vita Life Sciences Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Vita Life Sciences's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.


Vita Life Sciences Business Description

Traded in Other Exchanges
N/A
Address
Bath Road Kirrawee, Unit 1/ 102, Sydney, NSW, AUS, 2232
Vita Life Sciences Ltd is an Australian based pharmaceutical and healthcare company involved in formulating, packaging, sales, and distribution of vitamins and supplements. The company produces a wide range of premium supplements, vitamins, minerals, herbs and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, Herbs of Gold brands throughout Asia-Pacific region. The company has four reportable segments which include The Australia segment comprises of sale of Herbs of Gold range in Australia and exports into China. The Singapore and Malaysia segment, comprise of Vitahealth and Herbs of Gold range in both countries The other market segment comprises of Vitahealth ranges.

Vita Life Sciences Headlines

No Headlines